Literature DB >> 29046291

Diabetic Kidney Disease.

Lili Tong1, Sharon G Adler2.   

Abstract

Entities:  

Keywords:  Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cerebrovascular Disorders; Chronic; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Dyslipidemias; Gastroparesis; Humans; Kidney Failure; Life Style; Mineralocorticoid Receptor Antagonists; Peptidyl-Dipeptidase A; Peripheral Arterial Disease; Renal Insufficiency; Renin-Angiotensin System; Smoking Cessation; Type 2; Weight Loss; albuminuria; blood pressure; coronary artery disease; heart failure; proteinuria; risk factors

Mesh：

Substances：

Year:  2017        PMID： 29046291      PMCID： PMC5967422          DOI： 10.2215/CJN.04650417

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  15 in total

Review 1.  The incidence and implications of aldosterone breakthrough.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Nat Clin Pract Nephrol       Date:  2007-09

2.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Authors:  Steven P Marso; Stephen C Bain; Agostino Consoli; Freddy G Eliaschewitz; Esteban Jódar; Lawrence A Leiter; Ildiko Lingvay; Julio Rosenstock; Jochen Seufert; Mark L Warren; Vincent Woo; Oluf Hansen; Anders G Holst; Jonas Pettersson; Tina Vilsbøll
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

Review 3.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

4.  Non diabetic renal disease in type 2 diabetes mellitus.

Authors:  Sachin S Soni; Swarnalata Gowrishankar; A Gopal Kishan; Anuradha Raman
Journal:  Nephrology (Carlton)       Date:  2006-12       Impact factor: 2.506

5.  The modern spectrum of renal biopsy findings in patients with diabetes.

Authors:  Shree G Sharma; Andrew S Bomback; Jai Radhakrishnan; Leal C Herlitz; Michael B Stokes; Glen S Markowitz; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-25       Impact factor: 8.237

6.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

Review 7.  Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world.

Authors:  Farshad Kajbaf; Paul Arnouts; Marc de Broe; Jean-Daniel Lalau
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-08-19       Impact factor: 2.890

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Nonalbuminuric renal insufficiency in type 2 diabetes.

Authors:  Richard J MacIsaac; Con Tsalamandris; Sianna Panagiotopoulos; Trudy J Smith; Karen J McNeil; George Jerums
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079
View more
  7 in total

1.  Deteriorated functional and structural brain networks and normally appearing functional-structural coupling in diabetic kidney disease: a graph theory-based magnetic resonance imaging study.

Authors:  Yun Fei Wang; Ping Gu; Jiong Zhang; Rongfeng Qi; Michael de Veer; Gang Zheng; Qiang Xu; Ya Liu; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

2.  MicroRNA-145-5p attenuates high glucose-induced apoptosis by targeting the Notch signaling pathway in podocytes.

Authors:  Bing Wei; Yi-Song Liu; Hai-Xia Guan
Journal:  Exp Ther Med       Date:  2020-01-07       Impact factor: 2.447

3.  Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease.

Authors:  Pingping Zhao; Junxin Yan; Binjing Pan; Jingfang Liu; Songbo Fu; Jianguo Cheng; Liting Wang; Gaojing Jing; Qiong Li
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-14       Impact factor: 3.249

Review 4.  Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Lei Cao; Meng-Yuan Zhu; Teng-Teng Liu; Lei Guo; Ye Lin; Xiao-Wei Nie; Jin-Song Bian
Journal:  Molecules       Date:  2019-08-06       Impact factor: 4.411

Review 5.  The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease.

Authors:  Zhenzhen Lu; Yifei Zhong; Wangyi Liu; Ling Xiang; Yueyi Deng
Journal:  J Diabetes Res       Date:  2019-08-25       Impact factor: 4.011

6.  The single nucleotide polymorphism rs11643718 in SLC12A3 is associated with the development of diabetic kidney disease in Chinese people with type 2 diabetes.

Authors:  J-F Yang; X-F Xiong; Y Xiao; L Wei; L Li; M Yang; Y-C Han; H Zhao; C-R Li; N Jiang; S Xiong; L-F Zeng; Z-G Zhou; S-P Liu; N-S Wang; Y Fan; L Sun
Journal:  Diabet Med       Date:  2020-07-23       Impact factor: 4.359

7.  Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis.

Authors:  Lauren Fusfeld; Jessica T Murphy; YooJin Yoon; Li Ying Kam; Kirsten E Peters; Pearl Lin Tan; Michael Shanik; Alexander Turchin
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.